Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Carl Zeiss Foundation supports interdisciplinary research consortium "Chemical BioMedicine"

06.09.2012
Innovative research concept jointly initiated by the Mainz University Medical Center and the JGU Biology and Chemistry institutes receives funding of €1 million

The new interdisciplinary research consortium "Chemical BioMedicine" (ChemBioMed) seeks to extract new materials from natural sources, such as fungi and deep-sea sponges, which could help dissect disease mechanisms and prevent illnesses.

The Carl Zeiss Foundation is supporting the innovative research collaboration between the University Medical Center Mainz and the Biology and Chemistry institutes of Johannes Gutenberg University Mainz (JGU) with €1 million. This sponsorship is being provided as part of the foundation's program "Promotion of University Research Structures."

Today it is mainly chemicals that are used worldwide for the prevention and treatment of illnesses such as cancer, Alzheimer's disease, and inflammatory disorders. However, natural products extracted from fungi or marine sponges used as sources of potential new active substances have a decisive advantage over purely synthetically-produced products: Evolution has already pre-tested them in living organisms.

Consequently, the new ChemBioMed project aims to develop a seamless research pipeline, starting with the extraction and identification of bioactive natural products, the analysis of their structure and synthesis, followed by the exploitation of their structure-activity relationship for appropriate biomedical applications. "To meet this ambitious challenge, we depend on exceptional minds as well as sophisticated technologies. So, physicians, chemists, biologists, and bioinformatics specialists need to join forces in the research concept," explains one of the two coordinators of the consortium, Professor Dr. Roland Stauber of the Department of Otolaryngology, Head, and Neck Surgery – Plastic Surgery at the Mainz University Medical Center.

It is often difficult to use natural products because of their complex structure, representing a major challenge for their synthesis, and because of their limited availability. "However, with our ample experience in the chemistry of natural products adopted over the last years we are now well prepared to overcome such obstacles," the second coordinator of the consortium, Professor Dr. Till Opatz of the Institute of Organic Chemistry and Director of the Natural Product Synthesis Center at JGU, continues.

In addition, the Institute of Biotechnology and Drug Research (IBWF) and the robotic platform at the Mainz Screening Center are major pillars promoting the workflow of the project. "Clearly, the current support by the Carl Zeiss Foundation has helped us reach a critical milestone, paving our road towards excellent research," summarizes Roland Stauber looking towards the future.

The Institute of Biotechnology and Drug Research (IBWF), cooperation partner in the Center of Natural Materials Research Rhineland-Palatinate – Center of Excellence in Integrated Natural Materials Research, is currently based in Kaiserslautern, but will soon be relocated to Johannes Gutenberg University Mainz. Among other things, the IBWF undertakes interdisciplinary, applied research with the aim of developing new active substances from natural sources. "We bring with us specialist knowledge and experience in the area of drug and natural materials research and look forward to cooperating and networking with the faculties of Biology, Chemistry, and Medicine at Mainz University to tap the scientific and economic potential," says PD. Dr. Eckhard Thines, Director of the IBWF and, from October 2012, Professor of Biotechnology and Drug Research at the Faculty of Biology at Mainz University.

Mainz University thus represents an ideal location for the new ChemBioMed project. Extensive contacts and the proximity to leading pharmaceutical companies will further help to efficiently combine fundamental and applied clinically-relevant research. Hence, JGU sees enormous scientific and economic potential in this research area – especially facing the increasing need for novel and more effective "chemical tools."

"A research concept of strategic importance has been promoted thanks to the support of the Carl Zeiss Foundation. This is another important step in establishing the Mainz science hub as an internationally important center for molecular medicine," states the Chief Scientific Officer of the Mainz University Medical Center, Professor Dr. Dr. Reinhard Urban.

"I especially welcome the intention that not only researchers but also students will benefit from this prestigious support. Because this future-oriented research concept complements our degree programs in Biomedical Chemistry, Biomedicine, and Applied Bioinformatics, it gives our students the chance to participate in research projects and applications at an early stage," says Professor Dr. Mechthild Dreyer, Vice President for Learning and Teaching at JGU. "This supports our concept of research-driven teaching and thus the integration of outstanding research and teaching as a quality hallmark of our university."

Petra Giegerich | idw
Further information:
http://www.uni-mainz.de/presse/15672_ENG_HTML.php

More articles from Awards Funding:

nachricht The quest for the oldest ice on Earth
14.11.2016 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung

nachricht Empa Innovation Award for new flame retardant
09.11.2016 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>